Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-25-000014
Filing Date
2025-03-04
Accepted
2025-03-04 16:15:09
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741122898.html 4  
1 FORM 4 wk-form4_1741122898.xml 4 4028
  Complete submission text file 0001894562-25-000014.txt   5443
Mailing Address 900 FIFTH AVENUE #8C NEW YORK NY 10021
Business Address
Gottesdiener Keith Michael (Reporting) CIK: 0001615856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 25704582

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)